Efficacy of alemtuzumab and gemcitabine in a patient with enteropathy-type T-cell lymphoma.
Davide
D
Soldini
Oreste
O
Mora
Franco
F
Cavalli
Emanuele
E
Zucca
Luca
L
Mazzucchelli
D000368:Aged; D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002446:Celiac Disease / Q000150:complications / Q000188:drug therapy; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016399:Lymphoma, T-Cell / Q000150:complications / Q000188:drug therapy*; D012008:Recurrence; D000093542:Gemcitabine
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D003841:Deoxycytidine; D000074323:Alemtuzumab; D000093542:Gemcitabine